Correlation Between Maat Pharma and Sopra Steria

Can any of the company-specific risk be diversified away by investing in both Maat Pharma and Sopra Steria at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maat Pharma and Sopra Steria into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maat Pharma SA and Sopra Steria Group, you can compare the effects of market volatilities on Maat Pharma and Sopra Steria and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maat Pharma with a short position of Sopra Steria. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maat Pharma and Sopra Steria.

Diversification Opportunities for Maat Pharma and Sopra Steria

-0.42

Correlation Coefficient

Maat Pharma  Sopra Steria

Very good diversification

The 3 months correlation between Maat and Sopra is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Maat Pharma SA and Sopra Steria Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sopra Steria Group and Maat Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maat Pharma SA are associated (or correlated) with Sopra Steria. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sopra Steria Group has no effect on the direction of Maat Pharma i.e., Maat Pharma and Sopra Steria go up and down completely randomly.

Pair Corralation between Maat Pharma and Sopra Steria

Assuming the 90 days trading horizon Maat Pharma is expected to generate 3.17 times less return on investment than Sopra Steria. In addition to that, Maat Pharma is 1.56 times more volatile than Sopra Steria Group. It trades about 0.01 of its total potential returns per unit of risk. Sopra Steria Group is currently generating about 0.03 per unit of volatility. If you would invest  14,024  in Sopra Steria Group on September 26, 2024 and sell it today you would earn a total of  2,716  from holding Sopra Steria Group or generate 19.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Maat Pharma SA  vs.  Sopra Steria Group

Maat Pharma SA

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Maat Pharma SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maat Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Sopra Steria Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sopra Steria Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Maat Pharma and Sopra Steria

The main advantage of trading using opposite Maat Pharma and Sopra Steria positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maat Pharma position performs unexpectedly, Sopra Steria can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sopra Steria will offset losses from the drop in Sopra Steria's long position.

The idea behind Maat Pharma SA and Sopra Steria Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.